Q5100 Injection ustekinumab-kfce, 1 milligrams
Also known as: Sotyktu injection, ustekinumab-kfce
Injection of ustekinumab-kfce (Sotyktu) biosimilar per 1 milligram, for immunosuppressive therapy.
In Plain Language
biologic immunosuppressive drug; inflammatory disease treatment
Clinical Context
Used for various inflammatory and autoimmune conditions requiring selective immune modulation.
RVU Information
CPT Q5100 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5100?
CPT Q5100 (Injection ustekinumab-kfce, 1 milligrams) is a Q Codes code. Injection of ustekinumab-kfce (Sotyktu) biosimilar per 1 milligram, for immunosuppressive therapy.
Is Q5100 covered by insurance?
Q5100 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for various inflammatory and autoimmune conditions requiring selective immune modulation.
When is CPT Q5100 used?
Used for various inflammatory and autoimmune conditions requiring selective immune modulation.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.